Translational Mass Spectrometry Research Group
Working closely with the Great Ormond Street Hospital, National Hospital of Neurology & Neurosurgery and the Institute of Cardiovascular Sciences, my group's aim is to bring together state-of-the-art mass spectrometry with precision and stratified medicine, to find new drug targets, elucidate disease mechanisms, identify new biomarkers and develop new and more precise tests for the NHS.
Selected Grants
- 2017-2022: NIHR Mass Spectrometry Research Centre £150,000
- 2017-2020: Academic Clinical Fellow, Biomarkers of Poly Cystic Ovary Disease: GOSH BRC £35,000
- 2016-2018: Analysis of small molecule therapy trial using lipidomics and proteomic. Genzyme £64,000
- 2015-2019: Alzheimer’s Disease pathology within the ageing physiology (ADAGE) : JPND call: EU/MRC €554,958 (£317,528)
- 2015-2018: The continuum between healthy ageing and idiopathic Parkinson Disease within a propagation perspective of inflammation and damage: the search for new diagnostic, prognostic and therapeutic targets. Acronym: PROPAG-AGEING: PI at UCL, European Union: Euros 247,688
- 2015-2020: UK Genetic Frontotemporal dementia Initiative (UK GENFI); funding from the MRC, total amount £3,233,964 FEC (Co-PI)
- 2015-2018: Hepatocyte and mesenchymal stromal cell co-encapsulation in alginate microbeads as therapy of acute liver failure. Celine Filippi, Wendy Heywood & Kevin Mills (co-PI) i4i Challenge Awards NIHR £716,272 (£369,481 to UCL)
- 2013-2020: Mass Spectrometry Equipment grant: Lipidomic, metabolomics and high throughput drug screening capability SLMS £607,000 (PI)
- 2013-2019: Health and the Understanding of Metabolism, Aging and Nutrition (Human)- European Union SME-Targeted Collaborative Project 613,000 Euros (PI) (£514,920)
- 2013-2018: Analysis of lysosmal storage products in biological fluids, Sanofi (Genzyme), £87,500
Close
